Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Volitionrx (VNRX) Operating Expenses (2019 - 2025)

Historic Operating Expenses for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $5.7 million.

  • Volitionrx's Operating Expenses fell 969.48% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 2269.32%. This contributed to the annual value of $28.3 million for FY2024, which is 2313.34% down from last year.
  • Latest data reveals that Volitionrx reported Operating Expenses of $5.7 million as of Q3 2025, which was down 969.48% from $6.7 million recorded in Q2 2025.
  • Over the past 5 years, Volitionrx's Operating Expenses peaked at $9.8 million during Q2 2023, and registered a low of $5.7 million during Q3 2025.
  • Its 5-year average for Operating Expenses is $7.6 million, with a median of $7.8 million in 2022.
  • As far as peak fluctuations go, Volitionrx's Operating Expenses skyrocketed by 6843.03% in 2021, and later crashed by 3351.92% in 2024.
  • Quarter analysis of 5 years shows Volitionrx's Operating Expenses stood at $8.8 million in 2021, then decreased by 7.6% to $8.1 million in 2022, then increased by 10.51% to $9.0 million in 2023, then tumbled by 33.52% to $6.0 million in 2024, then dropped by 4.1% to $5.7 million in 2025.
  • Its Operating Expenses was $5.7 million in Q3 2025, compared to $6.7 million in Q2 2025 and $5.8 million in Q1 2025.